|
Nov 2
|
Zoetis' (ZTS) Q3 Earnings Beat, Revenues Miss by a Whisker
|
|
Sep 12
|
Ligand Pharmaceuticals (LGND) Dips More Than Broader Markets: What You Should Know
|
|
Sep 8
|
Novan reaches deals to sell assets in bankruptcy case
|
|
Sep 7
|
Ligand (LGND) Down 8.8% Since Last Earnings Report: Can It Rebound?
|
|
Jun 28
|
Sanofi (SNY) Atopic Dermatitis Drug Meets Goals in Phase II Study
|
|
Jun 27
|
Find Stocks to Buy in July that are Gaining More Attention on Wall Street
|
|
Jun 26
|
Is GSK PLC Sponsored ADR (GSK) Stock Outpacing Its Medical Peers This Year?
|
|
Jun 23
|
Humana's (HUM) CenterWell Unit Plans to Expand in Tennessee
|
|
Jun 23
|
LGND vs. ILMN: Which Stock Is the Better Value Option?
|
|
Apr 28
|
Intercept (ICPT) Q1 Earnings Miss Estimates, Revenues Up Y/Y
|
|
Apr 27
|
Alkermes (ALKS) Q1 Earnings & Revenues Beat Estimates
|
|
Apr 24
|
Ligand to Report First Quarter 2023 Financial Results on May 4, 2023
|